
Rhys Grinter
@rhys__g
Lab Head in the Department of Microbiology at Monash University studying the structural basis of bacterial disease.
ID: 38853255
09-05-2009 13:35:03
3,3K Tweet
2,2K Takipçi
1,1K Takip Edilen

SCANZ Crystal35 continue in the afternoon, with 2 sessions ;-) Pleasure to hear from Begona Heras Megan Maher Rhys Grinter and David Jacques Then time to catch up with friends for dinner ♥️




PM Session has commenced with Dr. Felix Bennetts Monash Institute of Pharmaceutical Sciences with his presentation on "Decoding the P2X1 receptor structural insights and drug development" 👏 Bio21 Institute WEHI (Walter and Eliza Hall Institute) Molecular Horizons @ UOW Australian Research Council


Day 2 of the #CCeMMP Symposium has begun with our industry speaker Dr. Nie Xin Thermo Fisher sharing insights into "New advances in cryo-electron microscopy: from basic research to translational science" 🙌 Monash Institute of Pharmaceutical Sciences WEHI (Walter and Eliza Hall Institute) Bio21 Institute Molecular Horizons @ UOW Australian Research Council


The next presenter is Rhys Grinter Bio21 Institute showcasing his research on "Inhibiting bacteria heme-piracy using de novo designed proteins" 👏 Monash Institute of Pharmaceutical Sciences WEHI (Walter and Eliza Hall Institute) Molecular Horizons @ UOW Australian Research Council


Final speaker for our AM session is Mahmuda Yeasmin Monash Institute of Pharmaceutical Sciences presenting "Structural basis of the clinical candidates at muscarinic acetylcholine receptors" 👏 Bio21 Institute Molecular Horizons @ UOW WEHI (Walter and Eliza Hall Institute) Australian Research Council




Absolutely thrilled that our ARC #DP25 was funded 🥹 I'm so proud of our team of talented #womeninSTEM - Dr Lesley Cheng and Emily Mackie 🙌🏻 Thank you to the College of Experts, assessors, mentors and my amazing team Uni of Adelaide! Can't wait to get this project started 🎉🌱




We are excited to share pre-prints describing a successful foray into ML-driven protein design. With Rhys Grinter we designed proteins to potently inhibit CRISPR-Cas13 (doi.org/10.1101/2024.1…) or block heme piracy by pathogenic E. coli (doi.org/10.1101/2024.1…):

Excited to share my first-author preprint as part of the Gavin Knott Lab! Using de novo protein design, we developed anti-CRISPRs to potently inhibit CRISPR-Cas13. Huge thanks to my amazing co-authors ! #CRISPR biorxiv.org/content/10.110…

Thrilled to see our work on high-resolution #cryoem using a common LaB6 120-keV TEM and sub–200-keV direct electron detector, now online Science Advances. science.org/doi/10.1126/sc… . A collaboration with Gatan Microscopy, @GeorgRamm, and Ramaciotti Centre for Cryo EM.


